-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Zentalis Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
- Zentalis Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $12.7M, a 4.73% decline year-over-year.
- Zentalis Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $53.3M, a 13.4% increase year-over-year.
- Zentalis Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $54.8M, a 17% increase from 2022.
- Zentalis Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $46.8M, a 31.1% increase from 2021.
- Zentalis Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $35.7M, a 54.4% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)